NOVALIX BELGIUM
The computed 12-month bankruptcy probability of NOVALIX BELGIUM is 1.6% (moderate). The 2024 annual accounts show negative equity (€-44k) and a net result of €-58k. Equity is shrinking by ~141.9% per year across the filed fiscal years. Its solvency ranks better than 13% of 43 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-44k |
| Net result | €-58k |
| Staff (FTE) | 39.5 |
| Better than sector | 13% |
Mixed profile: strong on profitability, weaker on health.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -4.1% | 53.3% | |
| Net result | €-58k | €-19k | |
| Equity | €-44k | €685k | |
| Gross operating margin | €2.79M | €7k | |
| Staff costs | €2.77M | €723k |
Show 7 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | - |
| Net profit | €-58k |
| Cash flow | - |
| Staff costs | €2.77M |
| Income taxes | €12k |
| Dividends | - |
| Total assets | €1.08M |
| Equity | €-44k |
| Debt | €1.13M |
| of which ≤ 1y | €1.13M |
| of which > 1y | - |
| Working capital | €-46k |
| Employees (FTE) | 39.5 |
| 2024 | |
|---|---|
| Current ratio | 0.96 |
| Quick ratio | 0.96 |
| Working capital ratio | -4.2% |
| Solvency | -4.1% |
| Debt / equity | -25.58 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -5.3% |
| ROE | 131.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (21 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.08M |
| Fixed assets | 21/28 | €2k |
| Financial fixed assets | 28 | €2k |
| Current assets | 29/58 | €1.08M |
| Amounts receivable within one year | 40/41 | €402k |
| Cash & bank | 54/58 | €679k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.08M |
| Equity | 10/15 | €-44k |
| Contributions / capital | 10/11 | €10k |
| Accumulated profits (losses) | 14 | €-54k |
| Amounts payable | 17/49 | €1.13M |
| Amounts payable within one year | 42/48 | €1.13M |
| Trade debts payable within one year | 44 | €613k |
| Income statement | ||
| Gross operating margin | 9900 | €2.79M |
| Operating result | 9901 | €23k |
| Financial income | 75 | €80 |
| Financial charges | 65 | €69k |
| Result before taxes | 9903 | €-46k |
| Income taxes | 67/77 | €12k |
| Net result for the period | 9904 | €-58k |
| Result to be appropriated | 9905 | €-58k |
-
REYNAERT CoralieDirector (executive)State Gazette act 24165075 (22-11-2024)Current22-11-2024 → present
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Private limited company(610) |
| Incorporation | 07-04-2022 |
| Status | Active |
| Postal code | 1420 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25744D0293/00R003 | Wallonia | 7,876 m² | 1 · 860 m² | 17.9 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
22-11-2024 Restructuring of share classes
Technical details
{
"events": [
{
"kind": "share_class_creation",
"after_eur": 1910000.0,
"delta_eur": 1900000.0,
"before_eur": 10000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "NOVALIX",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 1900000,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1900000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Jacques WATHELET",
"firm_city": null,
"firm_name": "WATHELET \u0026 NAVEZ, Notaires Associ\u00E9s",
"office_city": "Wavre",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-11-22",
"filing_date": "2022-01-13",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2024-10-24",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Renaud de Borman"
},
"subject_company": {
"kbo": "0784.616.271",
"name_full": "NOVALIX BELGIUM",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": null,
"pct": 100.0,
"kind": "org",
"name": "NOVALIX",
"role": "aandeelhouder",
"n_shares": 1910000,
"share_class": null
}
],
"share_classes_after": []
}17-06-2022 Capital increase of €1,900,000 to €1,910,000
- €10.000 → €1.910.000
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "apport_incorporation",
"after_eur": 1910000.0,
"delta_eur": 1900000.0,
"before_eur": 10000.0,
"subscribers": [
{
"kbo": "0783.357.449",
"rrn": null,
"kind": "org",
"name": "NOVALIX",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "industrie",
"n_shares_subscribed": 1900000,
"contribution_amount_eur": 1900000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1900000,
"with_new_shares": true,
"nominal_value_eur": 1.0,
"issue_price_per_share_eur": 1.0
},
"decrease_purpose": null,
"contribution_type": "industrie",
"paid_up_delta_eur": 1900000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 1910000.0,
"delta_eur": 1900000.0,
"before_eur": 10000.0,
"subscribers": [
{
"kbo": "0783.357.449",
"rrn": null,
"kind": "org",
"name": "NOVALIX",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": null,
"n_shares_subscribed": 1900000,
"contribution_amount_eur": 1900000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1900000,
"with_new_shares": true,
"nominal_value_eur": 1.0,
"issue_price_per_share_eur": 1.0
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": 1900000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Edouard-Jean NAVEZ",
"firm_city": null,
"firm_name": "WATHELET \u0026 NAVEZ, Notaires Associ\u00E9s",
"office_city": "Wavre",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2022-06-17",
"filing_date": "2022-06-07",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2022-06-02",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": "2022-05-24"
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "RdB",
"ibr_number": "0891.185.124",
"mission_type": "apport_nature",
"individual_name": "Renaud de Borman"
},
"subject_company": {
"kbo": "0784.616.271",
"name_full": "NOVALIX BELGIUM",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Projet d\u0027apport de branche d\u0027activit\u00E9",
"Rapport \u00E9crit et circonstanci\u00E9 du Pr\u00E9sident de l\u0027organe d\u0027administration",
"Rapport du r\u00E9viseur d\u0027entreprise",
"expedition",
"statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": "0783.357.449",
"pct": 100.0,
"kind": "org",
"name": "NOVALIX",
"role": "aandeelhouder",
"n_shares": 1910000,
"share_class": null
}
],
"share_classes_after": []
}25-04-2022 Restructuring of share classes
Technical details
{
"events": [
{
"kind": "share_class_creation",
"after_eur": 1910000.0,
"delta_eur": 1900000.0,
"before_eur": 10000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "NOVALIX S.A.S.",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": null,
"n_shares_subscribed": 1900000,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1900000,
"with_new_shares": true,
"nominal_value_eur": 1.0,
"issue_price_per_share_eur": 1.0
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 1900000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Edouard-Jean Navez",
"firm_city": null,
"firm_name": null,
"office_city": "Wavre",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2022-04-25",
"filing_date": "2022-03-18",
"act_kind_objet": "Objet de l\u0027acte :"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": null,
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2022-03-18"
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": "partial_split",
"individual_name": null
},
"subject_company": {
"kbo": "0784.616.271",
"name_full": "NOVALIX BELGIUM",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stephan JENN",
"org_rep_person_name": null,
"person_role_at_subject": "g\u00E9rant"
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "NOVALIX S.A.S.",
"role": "aandeelhouder",
"n_shares": 1900000,
"share_class": null
}
],
"share_classes_after": []
}| Legal nameFR | NOVALIX BELGIUM |